1. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
- Author
-
YUN LUO, PING ZHANG, HAN-QING ZENG, SHI-FENG LOU, and DAO-XIN WANG
- Subjects
GINSENOSIDES ,CANCER cells ,APOPTOSIS ,BCL-2 genes ,GINSENG ,ANTINEOPLASTIC agents - Abstract
Ginsenoside Rg3 is one of the main constituents isolated from Panax ginseng, and exhibits cytotoxic effects against cancer cells. The present study aimed to investigate the effects of ginsenoside Rg3 on human multiple myeloma cells, and determine the underlying molecular mechanisms. The cells were exposed to ginsenoside Rg3 at various concentrations (0-80 µM) for 48 h. A subsequent cell proliferation assay demonstrated that treatment with ginsenoside Rg3 resulted in a dose-dependent inhibition of the proliferation of U266 and RPMI8226 cells. Furthermore, exposure to ginsenoside Rg3 led to a marked increase in the rate of apoptosis in the U266 cells, coupled with increased caspase-3 activity. The ginsenoside Rg3-treated cells also exhibited an elevation in the expression of B-cell lymphoma 2-associated X protein (Bax), a pro-apoptotic protein. Notably, knockdown of Bax protected the U266 cells from Rg3-induced apoptosis. Overall, these findings suggested that ginsenoside Rg3 induced apoptosis in multiple myeloma cells, at least partially, through upregulation of the expression of Bax. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF